by Eric Christianson | Jul 7, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Donepezil (Aricept) is an acetylcholinesterase inhibitor that is used to help manage symptoms of dementia. I get asked quite a few questions about dementia and, more specifically, dementia-related medications. Here’s a recent question I received; If a patient is...
by Eric Christianson | Jul 3, 2019 | Educational Case Studies For Pharmacists, Neurology, Pain, and Musculoskeletal Case Studies
In this case scenario, I discuss some ideas as to how I would handle a patient on duplicate dopamine agonists. A 58-year-old female has a history of diabetes, restless legs, anemia, and GERD. Her major concern has been with her restless legs as she has not been able...
by Eric Christianson | Jun 26, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I recently did a podcast episode on heparin (which you can listen to below) and I did not mention hair loss as a potential adverse effect. In addition to heparin, it turns out there is data on other anticoagulants and this adverse effect as well. That begs the...
by Eric Christianson | Jun 23, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Alpha blockers are most frequently used in clinical practice to manage symptoms of BPH and probably less commonly used for hypertension. Here are a few relevant clinical practice pearls that are important to remember. Orthostasis/Syncope Alpha blockers are notorious...
by Eric Christianson | Jun 19, 2019 | Career Advice for Pharmacy Students, Residents and New Pharmacists, Personal Stories From The Front Lines of Clinical Pharmacy, Pharmacist Legislative Advocacy
As a profession, we know that we need to expand opportunities for pharmacists. I don’t have any data with this post to back me up, but I can “feel” the growth of pharmacists entering practice into clinics. This is a really good thing for pharmacists...
